Stock Overview
Shukra Pharmaceuticals Share Price

Shukra Pharmaceuticals Share Price

51.93
+0.00 (0.00%)
NSE
BSE
04 Sep, 2026 • 03:30 PM
NSE: SHUKRAPHAR | Pharmaceuticals | Small Cap
Buy

Shukra Pharmaceuticals Share Price Today


As of 5 Sep 2026, Shukra Pharmaceuticals share price is ₹52. The stock opened at ₹53 and had closed at ₹52 the previous day. During today’s trading session, Shukra Pharmaceuticals share price moved between ₹51.66 and ₹55.54, with an average price for the day of ₹53.60. Over the last 52 weeks, the stock has recorded a low of ₹40.06 and a high of ₹55.54. In terms of performance, Shukra Pharmaceuticals share price has increased by 26.3% over the past six months and has declined by 0% over the last year.

Shukra Pharmaceuticals Stock Performance

1W Return
17.28%
1M Return
0.00%
6M Return
0.00%
1Y Return
0.00%
3Y Return
0.00%
Today's High
₹55.54
Today's Low
₹51.66
52-Week High
₹55.54
52-Week Low
₹40.06
Prev. Close
₹51.93
Open
₹53.39
Face Value
₹1
Mkt Cap (Cr.)
₹2,289
PE Ratio
63.37

Shukra Pharmaceuticals Share Price Chart

Shukra Pharmaceuticals Company background

Founded in: 1993
Managing director: Dakshesh Shah
Shukra Pharmaceuticals Limited, formerly known Relish Pharmaceuticals Limited was established in March, 1993 and later on the Company name was changed from Relish Pharmaceuticals Limited to Shukra Pharmaceuticals Limited effective on September 22, 2016. The Company is presently engaged in the business of manufacturing and trading of pharmaceuticals formulations and laboratory testing. The company provides varieties of products to the clientele. Their product portfolio includes Antibiotics (Penicillin), Anti Biotics (Cephalosporin), Anti Biotics, Macrolides, Quinolones, Anti Bacterial, Anti Fungal, Anti Malarial, Anti Viral, Anti Protozoal, Anti Anthelmintic, Sedative and Tranquilliser, Anti Depressant, Anti Manic, Anti Emetic, Anti Ulcer, Beta Blockers, Diuretics, Analgesic, Analgesic (NASID), Muscle Relaxants, Anti Tuberculosis, Vitamin Products, Anti Allergics, Corticosteroids, Hyper and Hypoglycemic, Others.The company has four manufacturing divisions namely tablets (General and Beta Lactum) Capsules (General and Beta Lactum), Liquid and small volume parental. Their manufacturing unit is located at Rakanpur in Gujarat.The company customers include leading Manufacturers like Cadila Healthcare Limited (Zydus), Intas Pharmaceuticals Limited, Cadila Pharmaceuticals Limited, Makers Laboratories Limited, Agenta Pharma Limited etc.The company has assisted in the development and manufacture of a wide variety of drugs and dosage forms and potency variations for many prestigious pharmaceuticals companies around the world.In FY 201314, the Company got approval from Honble High Court of Gujarat for revival of Relish Pharmaceuticals Limited and Amalgamation of Proper Dealcomm Private Limited with the erstwhile Relish Pharmaceuticals Limited and Reorganization of Share Capital of Relish Pharmaceuticals Limited through the Scheme of Arrangement vide Honble High Court of Gujarat order dated 20 December, 2013.The Company has achieved WHOGMP certification, successfully securing a partnership with Meril Healthcare for robotic surgery projects in October 2025.

Shukra Pharmaceuticals Financial Highlights


For the full year FY2026–2027, revenue reached ₹61.31 crore and profit touched at ₹22.06 crore.
Shukra Pharmaceuticals Fundamental

Market Cap (in crs)

2,289.01

Face Value

1

Turnover (in lacs)

2,096.15

Key Metrics

Qtr Change %
98.47% Gain from 52W Low
81.7
Dividend yield 1yr %
0

Shukra Pharmaceuticals Key Financials

View more
Use arrow keys to navigate between tabs, Enter or Space to select, Home and End to go to first or last tab.
Use arrow keys to navigate between tabs, Enter or Space to select, Home and End to go to first or last tab.
Loading chart...
Shukra Pharmaceuticals Result Highlights
  • Shukra Pharmaceuticals reported a 230.9% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Jun (Q1 FY 2026-27). On a year-on-year (YoY) basis, it witnessed a growth of 270.2%.
  • Its expenses for the quarter were down by 14.5% QoQ and up 14.8% YoY.
  • The net profit decreased 853.5% QoQ and increased 1158.3% YoY.
  • The earnings per share (EPS) of Shukra Pharmaceuticals stood at 0.3 during Q1 FY 2026-27.

Read more

Data Source: BSE, Company announcements

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

Shukra Pharmaceuticals Technical Analysis

Moving Averages Analysis
51.93
Current Price
Bullish Moving Averages
16
Bearish Moving Averages
0
Use arrow keys to navigate between tabs, Enter or Space to select, Home and End to go to first or last tab.
5 EMA
48.90
10 EMA
46.70
12 EMA
46.00
20 EMA
43.70
26 EMA
42.40
50 EMA
39.00
100 EMA
36.80
200 EMA
35.30

Delivery & Volume

Loading chart...

Delivery Volume %

Day

40.40%

Week

41.80%

Month

47.20%

Resistance & Support

53.08
Pivot
Resistance
First Resistance
54.38
Second Resistance
56.80
Third Resistance
58.10
Support
First Support
50.66
Second support
49.36
Third Support
46.94
Relative Strength Index
87.65
Money Flow Index
80.42
MACD
3.66
MACD Signal
3.08
Average True Range
2.74
Average Directional Index
34.15
Rate of Change (21)
42.79
Rate of Change (125)
26.33

Shukra Pharmaceuticals Peer comparison

Compare

Shukra Pharmaceuticals Shareholding Pattern

Use arrow keys to navigate between tabs, Enter or Space to select, Home and End to go to first or last tab.
Promoter
51%
Domestic Institutions
0.1%
Public
48.9%
Shukra Pharmaceuticals Latest News
03 SEP 2026

Shukra Pharmaceuticals - 524632 - Update On Date Of AGM

03 SEP 2026

Shukra Pharmaceuticals - 524632 - Announcement under Regulation 30 (LODR)-Dividend Updates

02 SEP 2026

Shukra Pharmaceuticals - 524632 - Board Meeting Outcome for Allottment Of Preference Shares

Shukra Pharmaceuticals Share Price FAQs

Shukra Pharmaceuticals Ltd share price is ₹51.93 in NSE and ₹51.96 in BSE as on 4/9/2026.

Shukra Pharmaceuticals Ltd share price in the past 1-year return was 0. The Shukra Pharmaceuticals Ltd share hit a 1-year low of Rs. 40.06 and a 1-year high of Rs. 55.54.

The market cap of Shukra Pharmaceuticals Ltd is Rs. 2289.01 Cr. as of 4/9/2026.

The PE ratios of Shukra Pharmaceuticals Ltd is 63.37 as of 4/9/2026.

The PB ratios of Shukra Pharmaceuticals Ltd is 22.86 as of 4/9/2026

You can easily buy Shukra Pharmaceuticals Ltd shares in Kotak Neo by opening a demat account and getting the KYC documents verified online.

The 52-week high and low of Shukra Pharmaceuticals Ltd share price is ₹55.54 and ₹40.06 as of 4/9/2026.

Please be aware that Shukra Pharmaceuticals Ltd stock prices are subject to continuous fluctuations due to various factors.